|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005953,
umls-concept:C0012634,
umls-concept:C0013018,
umls-concept:C0024264,
umls-concept:C0030705,
umls-concept:C0162597,
umls-concept:C0392756,
umls-concept:C1513143,
umls-concept:C1514485,
umls-concept:C1527169,
umls-concept:C1533691
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-19
|
|
pubmed:abstractText |
To investigate the ability of bone marrow (BM)-derived mesenchymal stromal cells (BM-MSCs) in suppressing the proliferation of stimulated lymphocytes across a range of conditions including autologous BM-MSCs derived from autoimmune disease (AD) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1462-0324
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
403-8
|
|
pubmed:dateRevised |
2007-9-6
|
|
pubmed:meshHeading |
pubmed-meshheading:16920750-Adipocytes,
pubmed-meshheading:16920750-Adult,
pubmed-meshheading:16920750-Aged,
pubmed-meshheading:16920750-Aged, 80 and over,
pubmed-meshheading:16920750-Antibodies, Monoclonal,
pubmed-meshheading:16920750-Antigens, CD3,
pubmed-meshheading:16920750-Autoimmune Diseases,
pubmed-meshheading:16920750-Bone Marrow Cells,
pubmed-meshheading:16920750-Cell Line, Transformed,
pubmed-meshheading:16920750-Cell Proliferation,
pubmed-meshheading:16920750-Cell Transformation, Viral,
pubmed-meshheading:16920750-Cells, Cultured,
pubmed-meshheading:16920750-Female,
pubmed-meshheading:16920750-Humans,
pubmed-meshheading:16920750-Lymphocyte Activation,
pubmed-meshheading:16920750-Male,
pubmed-meshheading:16920750-Mesenchymal Stem Cells,
pubmed-meshheading:16920750-Middle Aged,
pubmed-meshheading:16920750-Osteoblasts,
pubmed-meshheading:16920750-Rheumatic Diseases,
pubmed-meshheading:16920750-Tumor Cells, Cultured
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
|
|
pubmed:affiliation |
Department of Rheumatology, University of Basel, Basel, Switzerland. chiara.tyndall@fps-basel.ch
|
|
pubmed:publicationType |
Journal Article
|
